The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

被引:19
|
作者
Fu, Wing-Yu [1 ,2 ]
Ip, Nancy Y. [1 ,2 ,3 ]
机构
[1] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, State Key Lab Mol Neurosci,Clear Water Bay,Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Shenzhen Hong Kong Inst Brain Sci, HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen 518057, Guangdong, Peoples R China
关键词
Synapses; Genetic risks; Synaptic vesicles; Neurotransmitter release; Neurotransmission; Synaptic plasticity; Protein trafficking; GENOME-WIDE ASSOCIATION; APOE GENOTYPE; RECEPTOR FUNCTION; PROTEIN CD2AP; PLASTICITY; ADAM10; TREM2; BETA; PHOSPHORYLATION; MUTATIONS;
D O I
10.1016/j.semcdb.2022.07.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions. Due to the extended global life expectancy, the prevalence of AD is increasing among aging populations worldwide. While AD is a multifactorial disease, synaptic dysfunction is one of the major neuro-pathological changes that occur early in AD, before clinical symptoms appear, and is associated with the pro-gression of cognitive deterioration. However, the underlying pathological mechanisms leading to this synaptic dysfunction remains unclear. Recent large-scale genomic analyses have identified more than 40 genetic risk factors that are associated with AD. In this review, we discuss the functional roles of these genes in synapto-genesis and synaptic functions under physiological conditions, and how their functions are dysregulated in AD. This will provide insights into the contributions of these encoded proteins to synaptic dysfunction during AD pathogenesis.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [21] Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
    Tu, Shichun
    Okamoto, Shu-ichi
    Lipton, Stuart A.
    Xu, Huaxi
    MOLECULAR NEURODEGENERATION, 2014, 9 : 48
  • [22] Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
    Robert Nisticò
    Marco Pignatelli
    Sonia Piccinin
    Nicola B. Mercuri
    Graham Collingridge
    Molecular Neurobiology, 2012, 46 : 572 - 587
  • [23] Alzheimer's disease, amyloid peptide and synaptic dysfunction
    Hemar, Agnes
    Mulle, Christophe
    M S-MEDECINE SCIENCES, 2011, 27 (8-9): : 733 - 736
  • [24] Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
    Cai, Qian
    Tammineni, Prasad
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1087 - 1103
  • [25] Targeting Synaptic Dysfunction in Alzheimer's Disease Therapy
    Nistico, Robert
    Pignatelli, Marco
    Piccinin, Sonia
    Mercuri, Nicola B.
    Collingridge, Graham
    MOLECULAR NEUROBIOLOGY, 2012, 46 (03) : 572 - 587
  • [26] Redox driven synaptic dysfunction in Alzheimer's disease
    Ravindranath, Viji
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 139 : S2 - S2
  • [27] Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
    Tonnies, Eric
    Trushina, Eugenia
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1105 - 1121
  • [28] Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
    Shichun Tu
    Shu-ichi Okamoto
    Stuart A Lipton
    Huaxi Xu
    Molecular Neurodegeneration, 9
  • [29] Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction
    Foster, Jonathan
    Sohrabi, Hamid R.
    Verdile, Giuseppe
    Martins, Ralph
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (04) : 853 - 855
  • [30] Genetic risk factors for Alzheimer's disease in African Americans
    Murray, MM
    Clark, RF
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 63 - 63